Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A
Department of Biochemistry, Hiroshima University School of Medicine, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
J Biol Chem. 1999 Apr 16;274(16):10681-4. doi: 10.1074/jbc.274.16.10681.
Axin forms a complex with glycogen synthase kinase-3beta (GSK-3beta) and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin, thereby stimulating the degradation of beta-catenin. Because GSK-3beta also phosphorylates Axin in the complex, the physiological significance of the phosphorylation of Axin was examined. Treatment of COS cells with LiCl, a GSK-3beta inhibitor, and okadaic acid, a protein phosphatase inhibitor, decreased and increased, respectively, the cellular protein level of Axin. Pulse-chase analyses showed that the phosphorylated form of Axin was more stable than the unphosphorylated form and that an Axin mutant, in which the possible phosphorylation sites for GSK-3beta were mutated, exhibited a shorter half-life than wild type Axin. Dvl-1, which was genetically shown to function upstream of GSK-3beta, inhibited the phosphorylation of Axin by GSK-3beta in vitro. Furthermore, Wnt-3a-containing conditioned medium down-regulated Axin and accumulated beta-catenin in L cells and expression of Dvl-1(DeltaPDZ), in which the PDZ domain was deleted, suppressed this action of Wnt-3a. These results suggest that the phosphorylation of Axin is important for the regulation of its stability and that Wnt down-regulates Axin through Dvl.
Axin与糖原合酶激酶-3β(GSK-3β)及β-连环蛋白形成复合物,并促进GSK-3β依赖的β-连环蛋白磷酸化,从而刺激β-连环蛋白的降解。由于GSK-3β也会使复合物中的Axin磷酸化,因此对Axin磷酸化的生理意义进行了研究。用GSK-3β抑制剂LiCl和蛋白磷酸酶抑制剂冈田酸处理COS细胞,分别降低和增加了Axin的细胞蛋白水平。脉冲追踪分析表明,Axin的磷酸化形式比未磷酸化形式更稳定,并且一个GSK-3β可能的磷酸化位点发生突变的Axin突变体,其半衰期比野生型Axin短。遗传学研究表明在GSK-3β上游起作用的Dvl-1在体外抑制了GSK-3β对Axin的磷酸化。此外,含Wnt-3a的条件培养基下调了L细胞中的Axin并使β-连环蛋白积累,而缺失PDZ结构域的Dvl-1(DeltaPDZ)的表达抑制了Wnt-这3a的一作用。这些结果表明,Axin的磷酸化对其稳定性的调节很重要,并且Wnt通过Dvl下调Axin。